Debt to Equity Ratio Chart

View Debt to Equity Ratio for ACET.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 0.107
March 31, 2026 0.0992
December 31, 2025 0.0926
September 30, 2025 0.1423
June 30, 2025 0.1152
March 31, 2025 0.1006
December 31, 2024 0.0924
September 30, 2024 0.086
June 30, 2024 0.0814
March 31, 2024 0.0774
December 31, 2023 0.123
September 30, 2023 0.112
June 30, 2023 0.0947
March 31, 2023 0.0883
December 31, 2022 0.0719
September 30, 2022 0.0684
June 30, 2022 0.0763
March 31, 2022 0.0662
Date Value
December 31, 2021 0.0691
September 30, 2021 0.0945
June 30, 2021 0.09
March 31, 2021 0.0897
December 31, 2020 0.197
September 30, 2020 0.00
June 30, 2020 0.00
March 31, 2020 0.00
December 31, 2019 -1.890
September 30, 2019 0.00
June 30, 2019 0.00
March 31, 2019 0.00
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 0.00
December 31, 2017 0.00

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 0.0565
Alnylam Pharmaceuticals, Inc. 2.206
Anika Therapeutics, Inc. 0.1839
Savara, Inc. 0.2117
Vericel Corp. 0.2556